Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.71 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.71 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.71 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.71 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.71 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.71 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.71 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.71 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.71 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | GRK2 | P25098 | 2/20 | 0.57 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.55 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26645943 | 0.89 | HDAC3 (0.77) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL7482482 | 0.88 | MAPK1 (0.63) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL14351015 | 0.88 | MAPK1 (0.63) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL27910330 | 0.88 | MAPK1 (0.63) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL9312836 | 0.86 | HDAC3 (0.67) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL23229080 | 0.86 | MAPK1 (0.61) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL29195205 | 0.86 | HDAC3 (0.77) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL14426830 | 0.86 | HDAC3 (0.67) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL19364615 | 0.85 | MAPK1 (0.59) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL3034142 | 0.85 | MAPK1 (0.59) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008196-A1 | CLASS OF AMIDE COMPOUNDS AND PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 中国科学院上海药物研究所 | 2024-01-11 | — | — | WO | disclosed |
| US-20110229581-A1 | RELEASABLE CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS | ENZON PHARMACEUTICALS, INC. (US) | 2011-09-22 | — | — | US | disclosed |
| US-20110223257-A1 | RELEASABLE FUSOGENIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS | ENZON PHARMACEUTICALS, INC. (US) | 2011-09-15 | — | — | US | disclosed |
| EP-0505378-B1 | DELIVERY SYSTEM FOR AGRICULTURAL CHEMICALS | ISP INVESTMENTS INC (US) | 2001-01-03 | — | — | EP | disclosed |
| EP-0574492-B1 | STABILIZATION OF MICROEMULSIONS USING HYDROPHOBIC ACID BUFFERS | ISP INVESTMENTS INC (US) | 1999-05-12 | — | — | EP | disclosed |
| EP-0701398-A4 | INERT MATRIX COMPOSITION, PREPARATION THEREOF AND MICROEMULSIFIABLE CONCENTRATE | ISP INVESTMENTS INC (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0707444-A1 | STABLE EMULSIFIABLE GEL MATRIX FOR FORMING GEL CONCENTRATE WITH AGRICULTURAL CHEMICAL, AND AQUEOUS MACROEMULSION THEREFROM | ISP INVESTMENTS INC. (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0701398-A1 | INERT MATRIX COMPOSITION, PREPARATION THEREOF AND MICROEMULSIFIABLE CONCENTRATE | ISP INVESTMENTS INC. (US) | 1996-03-20 | — | — | EP | disclosed |
| WO-1995001723-A1 | STABLE EMULSIFIABLE GEL MATRIX FOR FORMING GEL CONCENTRATE WITH AGRICULTURAL CHEMICAL, AND AQUEOUS MACROEMULSION THEREFROM | ISP INVESTMENTS INC. (US) | 1995-01-19 | — | — | WO | disclosed |
| WO-1994028711-A1 | INERT MATRIX COMPOSITION, PREPARATION THEREOF AND MICROEMULSIFIABLE CONCENTRATE | ISP INVESTMENTS INC. (US) | 1994-12-22 | — | — | WO | disclosed |
| EP-0574492-A4 | STABILIZATION OF MICROEMULSIONS USING HYDROPHOBIC ACID BUFFERS. | ISP INVESTMENTS INC (US) | 1994-03-17 | — | — | EP | disclosed |
| EP-0574492-A1 | STABILIZATION OF MICROEMULSIONS USING HYDROPHOBIC ACID BUFFERS | ISP INVESTMENTS INC. (US) | 1993-12-22 | — | — | EP | disclosed |
| WO-1992013454-A1 | STABILIZATION OF MICROEMULSIONS USING HYDROPHOBIC ACID BUFFERS | ISP INVESTMENTS INC. (US) | 1992-08-20 | — | — | WO | disclosed |
| EP-0179118-B1 | HERBICIDAL COMPOSITIONS WITH PROLONGED ACTION AND IMPROVED SELECTIVITY | NITROKEMIA IPARTELEPEK (HU) | 1989-03-15 | — | — | EP | disclosed |
| EP-0083613-B1 | N-PHENYLPYRAZOLE DERIVATIVES USEFUL AS HERBICIDES | MAY & BAKER LIMITED (GB) | 1988-06-01 | — | — | EP | disclosed |
| EP-0084033-B1 | N-PHENYLPYRAZOLE DERIVATIVES | MAY & BAKER LIMITED (GB) | 1985-10-02 | — | — | EP | disclosed |
| EP-0053011-B1 | NEW HERBICIDAL NICOTINAMIDE DERIVATIVES | MAY & BAKER LIMITED (GB) | 1985-04-03 | — | — | EP | disclosed |
| US-3962307-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229581-A1 | RELEASABLE CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS | APLNR, LPAR6, ABHD16A | HDAC3 862/4885HDAC4 1821/4885HDAC1 1101/4885 |
| US-20110223257-A1 | RELEASABLE FUSOGENIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS | FUS, HNRNPUL2, HNRNPDL | HDAC3 2895/4885HDAC4 2927/4885HDAC1 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.